OR WAIT null SECS
© 2022 MJH Life Sciences and Applied Clinical Trials Online. All rights reserved.
© 2022 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
August 03, 2022
Survey among readers evaluates the trajectory of RWD and how it can be more widely adopted.
June 03, 2022
Addressing sources of tension on differentiating types of data.
May 02, 2022
By integrating real-world data more deeply into the process of clinical research, life sciences stakeholders can open up new possibilities for therapeutic development and the evidence-based treatment of hematologic cancers.
July 08, 2021
RWE can augment, extend, or enrich the findings from clinical trials to provide valuable evidence to support the development programs for product approvals.
June 14, 2019
C.K. Wang, MD, senior medical director at COTA Inc., discusses the impact of RWD and RWE in clinical oncology.
April 01, 2019
A look at the scope of the agency’s draft framework for evaluating the use of RWE to support new drug approvals and the implications for sponsors.
With outcomes from “real life” a critical compliment to clinical trial data, the importance of involving an epidemiologist at study inception is explored.
March 26, 2019
Karen Hill and Heather Fitzpatrick Medlin discuss the recent advancements and challenges in cardiovascular and metabolic studies, as well as strategies to address current obstacles and advance the industry further.
December 01, 2017
Study examines the growing integration of real-world data and evidence and the remaining roadblocks to adoption.
November 27, 2017
In this three-part blog series, we look at how electronic platforms can support and enhance data capture in several types of RWD programs: observational studies, pragmatic trials, and commercial programs.